Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Molecular & Cellular Proteomics : MCP|January 20, 2005
Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cellsApril Thelemann, Filippo Petti, Graeme Griffin, et al.
Cancer Research|October 19, 2005
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibitionStuart Thomson, Elizabeth Buck, Filippo Petti, et al.
Molecular Cancer Therapeutics|November 24, 2006
Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumorsElizabeth Buck, Alexandra Eyzaguirre, Eric Brown, et al.
ACS Infectious Diseases|August 6, 2021
Impact of Target Turnover on the Translation of Drug-Target Residence Time to Time-Dependent Antibacterial ActivityRajeswari Basu, Nan Wang, Sneha Basak, et al.
Plos Pathogens|December 17, 2019
Novel replisome-associated proteins at cellular replication forks in EBV-transformed B lymphocytesHuanzhou Xu, Ramon D Perez, Tiffany R Frey, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 4, 2025
Nrf2 Drives Epigenetic Reprogramming and Acts as the Master Regulator of KLF4 Expression and Activity in Arsenic-Induced TransformationZiwei Wang, Zhuoyue Bi, Jessica Bamrah, et al.
ACS Infectious Diseases|April 2, 2025
Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target VulnerabilityMingqian Wang, YongLe He, Siobhan A Cohen, et al.
Nature Communications|September 13, 2024
Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney diseaseNehaben A Gujarati, Bismark O Frimpong, Malaika Zaidi, et al.
Molecular Cancer Therapeutics|September 5, 2024
TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer CellsMichael Giarrizzo, Joseph F LaComb, Hetvi R Patel, et al.
Molecular Cancer Therapeutics|February 20, 2007
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibitionElizabeth Buck, Alexandra Eyzaguirre, Sharon Barr, et al.
Pageof 6